CUREFINI

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: CUREFINI
Generic name: PETROLATUM
Manufacturer: Miramar Cosmetics, Inc DBA Miramar Lab
Product type: HUMAN OTC DRUG
SPL set ID: 6a2610ca-ca80-451f-8fed-b982443a10b9
SPL ID: ed9a0410-02b7-47b7-82d2-4896e1e72dd6
Version: 2
Effective date: 2024-12-23
Source export date: 2026-10-12
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:53:21

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 15 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M016	openfda.application_number
brand name		CUREFINI	openfda.brand_name
generic name		PETROLATUM	openfda.generic_name
manufacturer name		Miramar Cosmetics, Inc DBA Miramar Lab	openfda.manufacturer_name
ndc	package	79974-203-06	openfda.package_ndc
ndc	package	79974-203-02	openfda.package_ndc
ndc	package	79974-203-04	openfda.package_ndc
ndc	product	79974-203	openfda.product_ndc
ndc11	package	79974020302	derived:openfda.package_ndc
ndc11	package	79974020304	derived:openfda.package_ndc
ndc11	package	79974020306	derived:openfda.package_ndc
rxcui		1043075	openfda.rxcui
spl id		ed9a0410-02b7-47b7-82d2-4896e1e72dd6	id
spl set id		6a2610ca-ca80-451f-8fed-b982443a10b9	set_id
unii		4T6H12BN9U	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: For external use only • Avoid contact with eyes. • If symptoms persist for more than seven days, discontinue use and consult physician. • Keep out of reach of children. If swallowed, consult physician. • Do not use if tamper evident seal is broken.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.